ERN1 and scleroderma: However, in this section, we highlight the possible mechanisms of IRE1α’s contribution to the progression of autoimmune diseases such as T1D, RA, inflammatory bowel disease (IBD), vitiligo, systemic lupus erythematosus (SLE), and scleroderma (Table 2).